XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares
Additional Paid- in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance, beginning of period (in shares) at Mar. 31, 2023   1,025      
Balance, beginning of period at Mar. 31, 2023 $ 4,051 $ 2 $ 1,216 $ 376 $ 2,457
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (5)       (5)
Net change in fair value of the effective portion of designated cash flow hedges, net of tax (14)     (14)  
Foreign currency translation adjustments, net of tax (10)     (10)  
Share-based compensation cost 443   443    
Tax withholding on vested shares from share-based payment arrangements (23)   (23)    
Reclassification of RSU awards previously liability-classified [1] 343   343    
Distribution to majority ordinary shareholder related to Pelion IOT Limited (12)       (12)
Balance, ending of period (in shares) at Sep. 30, 2023   1,025      
Balance, ending of period at Sep. 30, 2023 4,773 $ 2 1,979 352 2,440
Balance, beginning of period (in shares) at Jun. 30, 2023   1,025      
Balance, beginning of period at Jun. 30, 2023 4,221 $ 2 1,275 382 2,562
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (110)       (110)
Net change in fair value of the effective portion of designated cash flow hedges, net of tax (14)     (14)  
Foreign currency translation adjustments, net of tax (16)     (16)  
Share-based compensation cost 384   384    
Tax withholding on vested shares from share-based payment arrangements (23)   (23)    
Reclassification of RSU awards previously liability-classified [2] 343   343    
Distribution to majority ordinary shareholder related to Pelion IOT Limited (12)       (12)
Balance, ending of period (in shares) at Sep. 30, 2023   1,025      
Balance, ending of period at Sep. 30, 2023 $ 4,773 $ 2 1,979 352 2,440
Balance, beginning of period (in shares) at Mar. 31, 2024 1,040 1,040      
Balance, beginning of period at Mar. 31, 2024 $ 5,295 $ 2 2,171 371 2,751
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 330       330
Net change in fair value of the effective portion of designated cash flow hedges, net of tax 15     15  
Foreign currency translation adjustments, net of tax 24     24  
Share-based compensation cost 400   400    
Issuance of vested shares from share-based payment arrangements (in shares)   11      
Tax withholding on vested shares from share-based payment arrangements $ (52)   (52)    
Balance, ending of period (in shares) at Sep. 30, 2024 1,051 1,051      
Balance, ending of period at Sep. 30, 2024 $ 6,012 $ 2 2,519 410 3,081
Balance, beginning of period (in shares) at Jun. 30, 2024   1,048      
Balance, beginning of period at Jun. 30, 2024 5,663 $ 2 2,316 371 2,974
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 107       107
Net change in fair value of the effective portion of designated cash flow hedges, net of tax 14     14  
Foreign currency translation adjustments, net of tax 25     25  
Share-based compensation cost 218   218    
Issuance of vested shares from share-based payment arrangements (in shares)   3      
Tax withholding on vested shares from share-based payment arrangements $ (15)   (15)    
Balance, ending of period (in shares) at Sep. 30, 2024 1,051 1,051      
Balance, ending of period at Sep. 30, 2024 $ 6,012 $ 2 $ 2,519 $ 410 $ 3,081
[1] Includes approximately $212 million of share-based compensation cost recognized in the six months ended September 30, 2023 for RSU awards previously liability-classified.
[2] Includes approximately $129 million of share-based compensation cost recognized in the three months ended September 30, 2023 for restricted share units (“RSU”) awards previously liability-classified.